SALT LAKE CITY, Sept. 5, 2019 /PRNewswire/ — CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in a key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. Pending successful results of the trial, the company plans to submit a 510(k) application to the FDA for US marketing approval …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone